Should HIV testing for all pregnant women continue? Cost-effectiveness of universal antenatal testing compared to focused approaches across high to very low HIV prevalence settings

by Naoko Ishikawa, Shona Dalal, Cheryl Johnson et al.
J Int AIDS Soc. 2016; 19(1): 21212

9 pp. 344 kB
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5159683/pdf/JIAS-19-21212.pdf

HIV testing is the entry point for the elimination of mother-to-child transmission of HIV. Decreasing external funding for the HIV response in some low- and middle-income countries has triggered the question of whether a focused approach to HIV testing targeting pregnant women in high-burden areas should be considered. The authors conclude that universal approach to antenatal HIV testing achieves the best health outcomes and is cost-saving or cost-effective in the long term across the range of HIV prevalence settings. It is further a prerequisite for quality maternal and child healthcare and for the elimination of mother-to-child transmission of HIV.

(Visited 12 times, 1 visits today)
This entry was posted in General, HIV - AIDS - STI, Maternal & Child Health. Bookmark the permalink.